Nuvalent, Inc. (NUVL)
NASDAQ·Healthcare·Biotechnology
$101.81
-2.14%
Mkt Cap $7.97B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $6.82M | — | — | -$1.48 | -$1.29 | +12.84% | — | — |
| Q4 2025 Oct 30, 2025 | — | — | — | -$1.39 | -$1.70 | -22.30% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$1.27 | -$1.31 | -3.15% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$1.14 | -$1.18 | -3.51% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$1.04 | -$1.05 | -0.96% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.93 | -$1.28 | -37.03% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.76 | -$0.88 | -15.79% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.67 | -$0.69 | -2.99% | — | — |
| Q1 2024 Feb 27, 2024 | — | — | — | -$0.59 | -$0.62 | -5.08% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.59 | -$0.59 | +0.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.53 | -$0.51 | +3.77% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.51 | -$0.44 | +13.73% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.43 | -$0.49 | -13.95% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.46 | -$0.41 | +10.87% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$0.43 | -$0.38 | +11.63% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.40 | -$0.36 | +10.00% | — | — |
| Q1 2022 Mar 29, 2022 | — | $2.43M | — | -$0.32 | -$0.36 | -12.50% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.25 | -$0.39 | -56.00% | — | — |
| Q3 2021 Sep 8, 2021 | — | — | — | -$0.19 | -$3.17 | -1568.42% | — | — |
| Q3 2021 Jul 30, 2021 | — | — | — | — | -$0.30 | — | — | — |